The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer Akshay J. PatelAlex RichterGary W. Middleton Review Open access 04 January 2020 Pages: 325 - 342
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies Brooke E. WilsonBertrand RoutyVenessa T. Chin Original Article 21 December 2019 Pages: 343 - 354
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer Simer J. BainsHanna AbrahamssonAnne Hansen Ree Original Article Open access 31 December 2019 Pages: 355 - 364
Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients Junxun MaDanyang SunYi Hu Original Article 02 January 2020 Pages: 365 - 372
Lung cancer-derived extracellular vesicles: a possible mediator of mast cell activation in the tumor microenvironment Pazit SalamonYoseph A. MekoriIrit Shefler Original Article 02 January 2020 Pages: 373 - 381
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients Alessandra BattagliaAlexia BuzzonettiChristopher Nicodemus Original Article 03 January 2020 Pages: 383 - 397
Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study Guowei ZhangRuirui ChengZhiyong Ma Original Article 06 January 2020 Pages: 399 - 405
Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas Mikael RousselFaustine LhommeJonathan M. Irish Original Article 09 January 2020 Pages: 407 - 420
The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide Subhashis SarkarSachin K. S. ChauhanMichael O’Dwyer Original Article 09 January 2020 Pages: 421 - 434
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer Caroline BergenfelzAnna RoxåAnna-Maria Larsson Original Article Open access 10 January 2020 Pages: 435 - 448
Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy Remy ThomasHibah ShaathJulie Decock Original Article Open access 13 January 2020 Pages: 449 - 463
The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction Hongzhi QuanZhongyan ShanLiangjuan Fang Original Article 16 January 2020 Pages: 465 - 476
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial Steve BoudewijnsMartine BloemendalI. Jolanda M. de Vries Clinical Trial Report Open access 24 January 2020 Pages: 477 - 488
PD-L1 expression levels should be considered when identifying risk factors in NSCLC patients treated with nivolumab Pengfei LiGuowei Che Letter to the Editors 05 December 2019 Pages: 489 - 489
PCSK9 is a promising prognostic marker in patients with advanced NSCLC Aldo BonaventuraFrancesco GrossiFabrizio Montecucco Letter to the Editors 14 January 2020 Pages: 491 - 492
Retraction Note to: Bio‑HMGB1 from breast cancer contributes to M‑MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC‑like cells Zhaoliang SuPing NiJia Wang Retraction Note 24 January 2020 Pages: 493 - 493
